The Community Guide

- gsearch

Search Results

Narrow Results:

2024 1
2019 1

PIVI Partners Group 1

Journal Article 2

1 - 2 of 2 Results

Refine Results

Refine Results:

The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships

CITE Title : The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships Personal Author(s) : Bresee, Joseph S.;Lafond, Kathryn E.;McCarron, Margaret;Azziz-Baumgartner, Eduardo;Chu, Susan Y.;Ebama, Malembe;Hinman, Alan R.;Xeuatvongsa, Anonh;Bino, Silvia;Richardson, Dominique;Porter, Rachael M.;Moen, Ann;McKinlay, Mark; Corporate Authors(s) : PIVI Partners Group Published Date : July 06 2019;8-14-; Source : Vaccine. 37(35):5089-5095 URL : https://stacks.cdc.gov/view/cdc/91077 Bresee, Joseph S. et al. (2019). The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships. 37(35). Bresee, Joseph S. et al. "The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships" 37, no. 35 (2019) Bresee, Joseph S. et al. "The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships" vol. 37, no. 35, 2019 Export RIS Citation Information.

:

Bresee, Joseph S. ;

Lafond, Kathryn E.

July 06 2019 | Vaccine. 37(35):5089-5095

:

Influenza vaccination remains the most effective tool for reducing seasonal influenza disease burden. Few Low and Middle-Income Countries (LMICs) have...
Global VAX: A U.S. contribution to global COVID-19 vaccination efforts, 2021–2023

CITE Title : Global VAX: A U.S. contribution to global COVID-19 vaccination efforts, 2021–2023 Personal Author(s) : Dahl, Benjamin A.;Tritter, Beth;Butryn, Deena;Dahlke, Melissa;Browning, Sean;Gelting, Richard;Fleming, Monica;Ortiz, Nancy;Labrador, Jacqueline;Novak, Ryan;Fitter, David;Bell, Elizabeth;McGuire, Megan;Rosenbaum, Robert;Pulwer, Robert;Wun, Jolene;McCaffrey, Anna;Chowdhury, Maisoon;Parks, Nida;Cunningham, Marc;Mounts, Anthony;Curry, Dora;Richardson, Dominique;Grant, Gavin; Published Date : 9 17 2024;9-17-; Source : Vaccine. 42(Suppl 3):125827 URL : https://stacks.cdc.gov/view/cdc/162456 Dahl, Benjamin A. et al. (2024). Global VAX: A U.S. contribution to global COVID-19 vaccination efforts, 2021–2023. 42 Dahl, Benjamin A. et al. "Global VAX: A U.S. contribution to global COVID-19 vaccination efforts, 2021–2023" 42 (2024) Dahl, Benjamin A. et al. "Global VAX: A U.S. contribution to global COVID-19 vaccination efforts, 2021–2023" vol. 42, 2024 Export RIS Citation Information.

:

Dahl, Benjamin A. ;

Tritter, Beth

9 17 2024 | Vaccine. 42(Suppl 3):125827

:

In December 2021 the U.S. Government announced a new, whole-of-government $1.8 billion effort, the Initiative for Global Vaccine Access (Global VAX) i...